Abstract
Oligomer Aβ is the term utilized for multimeric but non-fibrillar forms of amyloid β-protein (Aβ). The most prominent property of oligomer Aβ is considered to be its solubility and structure. Here, we examined the histochemical localization of oligomer Aβ in AD brains. At present, little information is available on the structure and function of cerebral oligomer Aβ. We therefore studied the molecular localization of oligomer Aβ using a newly generated polyclonal mouse antisera against a variant Aβ with a deletion mutation of the 22nd glutamate that we found recently in a patient with familial Alzheimers disease. Intracellular as well as extracellular oligomer Aβ are herein discussed to define their structure and pathological roles in disease.
Keywords: Alzheimer disease, amyloid, Aβ, oligomer, synapse, recessive hereditary
Current Alzheimer Research
Title: Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimers Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form
Volume: 6 Issue: 2
Author(s): Kazuhiro Ito, Ken-Ichi Ishibashi, Takami Tomiyama, Tomohiro Umeda, Kei-Ichi Yamamoto, Erika Kitajima, Toshiki Idomoto, Toshie Nagatomo and Hiroshi Mori
Affiliation:
Keywords: Alzheimer disease, amyloid, Aβ, oligomer, synapse, recessive hereditary
Abstract: Oligomer Aβ is the term utilized for multimeric but non-fibrillar forms of amyloid β-protein (Aβ). The most prominent property of oligomer Aβ is considered to be its solubility and structure. Here, we examined the histochemical localization of oligomer Aβ in AD brains. At present, little information is available on the structure and function of cerebral oligomer Aβ. We therefore studied the molecular localization of oligomer Aβ using a newly generated polyclonal mouse antisera against a variant Aβ with a deletion mutation of the 22nd glutamate that we found recently in a patient with familial Alzheimers disease. Intracellular as well as extracellular oligomer Aβ are herein discussed to define their structure and pathological roles in disease.
Export Options
About this article
Cite this article as:
Ito Kazuhiro, Ishibashi Ken-Ichi, Tomiyama Takami, Umeda Tomohiro, Yamamoto Kei-Ichi, Kitajima Erika, Idomoto Toshiki, Nagatomo Toshie and Mori Hiroshi, Oligomeric Amyloid β -Protein as a Therapeutic Target in Alzheimers Disease: Its Significance Based on its Distinct Localization and the Occurrence of a Familial Variant Form, Current Alzheimer Research 2009; 6 (2) . https://dx.doi.org/10.2174/156720509787602889
DOI https://dx.doi.org/10.2174/156720509787602889 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
Call for Papers in Thematic Issues
New Advances in the Prevention, Diagnosis, Treatment, and Rehabilitation of Alzheimer's Disease
Aims and Scope: Introduction: Alzheimer's disease (AD) poses a significant global health challenge, with an increasing prevalence that demands concerted efforts to advance our understanding and strategies for prevention, diagnosis, treatment, and rehabilitation. This thematic issue aims to bring together cutting-edge research and innovative approaches from multidisciplinary perspectives to address ...read more
Current updates on the Role of Neuroinflammation in Neurodegenerative Disorders
Neuroinflammation is an invariable hallmark of chronic and acute neurodegenerative disorders and has long been considered a potential drug target for Alzheimer?s disease (AD) and dementia. Significant evidence of inflammatory processes as a feature of AD is provided by the presence of inflammatory markers in plasma, CSF and postmortem brain ...read more
Deep Learning for Advancing Alzheimer's Disease Research
Alzheimer's disease (AD) poses a significant global health challenge, with an increasing number of individuals affected yearly. Deep learning, a subfield of artificial intelligence, has shown immense potential in various domains, including healthcare. This thematic issue of Current Alzheimer Research explores the application of deep learning techniques in advancing our ...read more
Diagnostic and therapeutic biomarkers of dementia
Dementia affects 18 million people worldwide. Dementia is a syndrome of symptoms caused by brain disease, usually chronic or progressive, clinically characterized by multiple impairments of higher cortical functions such as memory, thinking, orientation, and learning. In addition, in the course of dementia, cognitive deficits are observed, which often hinder ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Tetrahydrobiopterin Pathway may Provide Novel Molecular Targets for Acute and Long Term Efficacy of Mood-Regulating Drugs
Current Pharmacogenomics and Personalized Medicine Psychotropic Medications and the Treatment of Human Prion Diseases
CNS & Neurological Disorders - Drug Targets The Role of Mitochondrial Function in Glutamate-Dependent Metabolism in Neuronal Cells
Current Pharmaceutical Design Rosuvastatin, Pravastatin, and Atorvastatin for the Treatment of Hypercholesterolaemia in HIV-Infected Patients Receiving Protease Inhibitors
Current HIV Research Current Understanding of Central Nervous System Drainage Systems: Implications in the Context of Neurodegenerative Diseases
Current Neuropharmacology The Premature Lottery in the Canadian Grey Zones
Current Pediatric Reviews Organelle Stress Sensors and Cell Death Mechanisms in Neurodegenerative Diseases
CNS & Neurological Disorders - Drug Targets Is Elevated Norepinephrine an Etiological Factor in Some Cases of Alzheimers Disease?
Current Alzheimer Research Nano Clinoptilolite: Highly Efficient Catalyst for the Synthesis of Chromene Derivatives Under Solvent-Free Conditions
Combinatorial Chemistry & High Throughput Screening Nutrition as a Health Determinant in Elderly Patients
Current Medicinal Chemistry Modulation of Inflammation as a Way of Delaying Alzheimer's Disease Progression: The Diet's Role
Current Alzheimer Research A Speech Recognition-based Solution for the Automatic Detection of Mild Cognitive Impairment from Spontaneous Speech
Current Alzheimer Research Risk Factors in Cardiovascular Disease in Systemic Lupus Erythematosus
Current Cardiology Reviews Regression to the Mean: Implications for Clinical Trials of Psychotropic Agents in Dementia
Current Alzheimer Research Hormonal Control of the Neuropeptide Y System
Current Protein & Peptide Science Targeting α7 Nicotinic Acetylcholine Receptor to Combat Inflammation in Cardio-Cerebral-Vascular Diseases
Current Drug Targets Cerebral Ischemia and Angiogenesis
Current Neurovascular Research Preventive Antidepressant use in Patients with Hepatitis C Treated with Interferon-Alfa: a Systematic Review
Current Psychiatry Reviews Sleep-Disordered Breathing and Cardiovascular Disease: Exploring Pathophysiology and Existing Data
Current Respiratory Medicine Reviews Patent Selections
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery